Cargando...
Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study
INTRODUCTION: The aim of the present study was to assess the long‐term (52‐week) efficacy and safety of ipragliflozin in insulin‐treated Japanese patients with type 1 diabetes mellitus and inadequate glycemic control. MATERIALS AND METHODS: In this 28‐week, open‐label extension of a multicenter, ran...
Guardado en:
| Publicado en: | J Diabetes Investig |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232286/ https://ncbi.nlm.nih.gov/pubmed/31743569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13181 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|